Literature DB >> 6395637

Orbital phlebography in patients with Tolosa-Hunt's syndrome in comparison with normal subjects.

J Hannerz, K Ericson, G Bergstrand.   

Abstract

Orbital phlebography has been reported to be pathologic in some patients with Tolosa-Hunt's syndrome (recurrent painful ophthalmoplegia). A systematic study of the phlebographic findings in Tolosa-Hunt's syndrome in comparison with a normal material seems not to have been performed. In this investigation, orbital phlebography was performed in 19 patients with Tolosa-Hunt's syndrome and in a reference group of 23 persons without the disease. In 13 of 19 patients (68%) with Tolosa-Hunt's syndrome, the phlebography was pathologic (narrowing or occlusion of particularly the third segment of the superior ophthalmic vein, partial occlusion of the cavernous sinus). Orbital phlebography was normal in all but one of the subjects in the reference group. The medical history of this subject in retrospect revealed symptoms other than painful ophthalmoplegia commonly found in patients with Tolosa-Hunt's syndrome, suggesting that he suffered from a variant of the disease causing the syndrome. In one patient with recurrent painful ophthalmoplegia a biopsy from an eye muscle showed venous vasculitis, probably indicating the basic pathology behind the phlebographic changes in patients with Tolosa-Hunt's syndrome.

Entities:  

Mesh:

Year:  1984        PMID: 6395637     DOI: 10.1177/028418518402500602

Source DB:  PubMed          Journal:  Acta Radiol Diagn (Stockh)        ISSN: 0567-8056


  2 in total

1.  Neurological and radiological studies in painful ophthalmoplegia: Tolosa-Hunt syndrome and orbital pseudotumour.

Authors:  Y Goto; I Goto; S Hosokawa
Journal:  J Neurol       Date:  1989-12       Impact factor: 4.849

2.  Orbital phlebography in idiopathic intracranial hypertension and chronic tension-type headache.

Authors:  Jan Hannerz; Kaj Ericson; Dan Greitz; Pernille Hanne Bro Skejo; Gunnar Edman
Journal:  Acta Radiol Short Rep       Date:  2013-10-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.